Results 281 to 290 of about 55,224 (387)

Editorial: Glial cells in homeostasis, neurodevelopment, and repair. [PDF]

Front Cell Neurosci
Cibelli A, Spray DC, Mola MG.
europepmc   +1 more source

Optogenetic Strategies to Dissect the Neural Circuits that Underlie Reward and Addiction

, 2012
A. M. Stamatakis, Garret D. Stuber
openalex   +2 more sources

Development of transgenic animals for optogenetic manipulation of mammalian nervous system function: Progress and prospects for behavioral neuroscience [PDF]

, 2013
Jonathan T. Ting, Guoping Feng
openalex   +1 more source

POT, an optogenetics-based endogenous protein degradation system. [PDF]

Commun Biol
Chen Y, Wang S, Zhang L, Peng D, Huang K, Ji B, Fu J, Xu Y.   +7 more
europepmc   +1 more source

Resistance of Optogenetically Evoked Motor Function to Global Ischemia and Reperfusion in Mouse in Vivo [PDF]

, 2013
Yicheng Xie, Xing‐Qiu Chen, Eitan Anenberg, Timothy H. Murphy   +3 more
openalex   +1 more source

Microscopy and spectroscopy approaches to study GPCR structure and function

British Journal of Pharmacology, EarlyView.
Abstract The GPCR signalling cascade is a key pathway responsible for the signal transduction of a multitude of physical and chemical stimuli, including light, odorants, neurotransmitters and hormones. Understanding the structural and functional properties of the GPCR cascade requires direct observation of signalling processes in high spatial and ...
Tomáš Fessl, Maria Majellaro, Alexey Bondar   +2 more
wiley   +1 more source

A new flavor of synthetic yeast communities sees the light. [PDF]

mBio
Rojas V, Rivera D, Ruiz C, Larrondo LF.
europepmc   +1 more source

Optogenetic techniques for the study of native potassium channels [PDF]

, 2013
Guillaume Sandoz, Joshua Levitz
openalex   +1 more source

ESG‐1‐60 and ESG‐1‐61: Novel dopamine D3 receptor‐preferring partial agonists/antagonists that inhibit cocaine taking and seeking in rodents

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Preclinical studies suggest that highly selective dopamine D3 receptor (D3R) antagonists or partial agonists hold promise for treating substance use disorders. However, their limited effectiveness in reducing cocaine self‐administration is a major drawback.
Omar Soler‐Cedeño, Bradley M. Keegan, Hannah Alton, Guo‐Hua Bi, Emily Linz, Caleb D. Vogt, Emma S. Gogarnoiu, Lei Shi, Amy Hauck Newman, Zheng‐Xiong Xi   +9 more
wiley   +1 more source

The current landscape of optogenetics for the enhancement of adoptive T-cell therapy. [PDF]

Discov Immunol
Smith GR, Lee MP, Jennings EK, James JR.
europepmc   +1 more source